As a registered USPTO patent agent, Daniel D. Wright wields his patent drafting and prosecution skills to secure profitable futures for the medicines and biotechnologies that shape modern diagnosis and treatment. 

Previously the sole in-house intellectual property counsel at Verseon Corporation, a San Francisco Bay Area pharmaceutical company, Daniel worked extensively on the prosecution of small molecule drug products and their formulations in sixteen different jurisdictions worldwide, as well as on the company’s proprietary molecular modeling platform. In his multi-faceted role at the company, he learned to assess the needs of an emerging enterprise and address the challenges of developing a patent portfolio that both establishes an immediate strength and fosters opportunity for further growth.

Over the course of his professional and academic careers, Daniel has drafted applications on an assortment of additional technologies, including batteries, ballistics, and distributed computing platforms. The skills and practical knowledge he has gained equips him to devise successful patent strategies for a broad range of innovations, particularly those that synthesize elements from divergent fields, as great advancements often do. 

Daniel holds a Masters of Science in Patent Law from the University of Notre Dame, Indiana, where he specialized in organic synthesis and analytical chemistry. He earned undergraduate degrees in chemistry and philosophy from the University of Notre Dame as part of the Glynn Family Honors program.